Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 43 results for leiomyoma

  1. Current evidence on the safety of ultrasound-guided high‑intensity transcutaneous focused ultrasound for symptomatic uterine fibroids shows there are well-recognised complications including skin burns. The evidence on efficacy is limited in quality. Therefore, this procedure should only be used with  special arrangements   for clinical governance, consent, and audit or research.

    high‑intensity transcutaneous focused ultrasound for symptomatic uterine fibroids shows there are well-recognised complications...

    Research recommendation
    Published
    15 November 2019

  2. Second-generation endometrial ablation for HMB associated with myometrial pathology:- Are outcomes after second-generation endometrial ablation for women with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial pathology?

    with HMB associated with myometrial pathology (adenomyosis and/or uterine fibroids) equivalent to those for women without myometrial...

    Research recommendation
    Published
    14 November 2018

  3. NICE encourages further research into the efficacy of MRI-guided transcutaneous focused ultrasound for uterine fibroids. Research studies should report long-term outcomes, including the need for further treatment. Data on the incidence and outcomes of subsequent pregnancy in patients who choose this procedure because they wish to maintain or improve their fertility are particularly important.

    the efficacy of MRI-guided transcutaneous focused ultrasound for uterine fibroids. Research studies should report long-term outcomes,...

    Research recommendation
    Published
    9 June 2015

  4. Gynaecological conditions: rates of hysterectomy (heavy menstrual bleeding) (IND58)

    This indicator covers rates of hysterectomy. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG77

    Network / system level indicators
    Last updated
    22 March 2024

  5. Ovarian cancer: recognition and initial management (CG122)

    This guideline covers detecting, diagnosing and treating women (18 years and older) who have, or are suspected of having, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer or borderline ovarian cancer. It aims to enable earlier detection of ovarian cancer and improve initial treatment.

    Clinical guideline
    Last updated
    2 October 2023
    View recommendations

    Sections for CG122

  6. The Sonata Treatment - Transcervical Radiofrequency Fibroid Ablation using Intrauterine Ultrasound

    Awaiting development [GID-MT603] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  7. Evidence on the safety of laparoscopic removal of uterine fibroids with power morcellation shows potentially serious complications. In particular there is a risk of spreading undiagnosed malignant tissue, which has higher prevalence in people who are postmenopausal or over 50. Evidence on the procedure's efficacy is limited in quantity. Therefore, further research should report details of patient selection, surgical technique (including any containment system used) and long-term outcomes.

    Question Evidence on the safety of laparoscopic removal of uterine fibroids with power morcellation shows potentially serious...

    Research recommendation
    Published
    30 September 2021

  8. Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding (TA78)

    Evidence-based recommendations on fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding in adults.

    Technology appraisal guidance
    Published
    28 April 2004
    View recommendations

    Sections for TA78

  9. Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions (IPG774)

    Evidence-based recommendations on vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions. This involves removing the uterus (womb), and sometimes the fallopian tubes and ovaries, through the vagina.

    Interventional procedures guidance
    Published
    25 October 2023
    View recommendations

    Sections for IPG774

  10. History of NICE

    interventional procedures guidance IPG1 Uterine artery embolisation for fibroids (July). Read more about interventional procedures 2005

  11. Laparo-endogastric surgery (IPG25)

    Evidence-based recommendations on laparo-endogastric surgery. This involves performing surgery for gastric wall lesions by passing a flexible telescope (endoscope) through the gullet and into the stomach, and a thin tube (laparascope) through a small cut in the upper abdomen.

    Interventional procedures guidance
    Published
    17 December 2003
    View recommendations

    Sections for IPG25

  12. Uterine artery embolisation for treating adenomyosis (IPG473)

    Evidence-based recommendations on uterine artery embolisation for treating adenomyosis. This involves injecting small particles to block the blood supply to the adenomyosis (thickening of the womb lining).

    Interventional procedures guidance
    Published
    16 December 2013
    View recommendations

    Sections for IPG473

  13. Laparoscopic techniques for hysterectomy (IPG239)

    Evidence-based recommendations on laparoscopic techniques for hysterectomy. This involves surgically removing the uterus using special instruments through small cuts in the abdomen (keyhole surgery).

    Interventional procedures guidance
    Published
    28 November 2007
    View recommendations

    Sections for IPG239

  14. Past appeals and decisions

    thisterone acetate for treating moderate to severe symptoms of uterine fibroids [ID3842] 7 September 2022 TA178 Renal cell carcinoma -...

  15. Ovarian cancer (QS18)

    This quality standard covers the recognition and initial management of ovarian cancer. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    21 May 2012
    View quality statements

    Sections for QS18